1. Международная классификация головных болей. Пер. В.В.Осиповой, Т.Г.Вознесенской. Изд. 2-е. 2003.
2. Rasmussen BK, Jensen R, Schroll M, Olesen J. Epidemiology of headache in a general population. Aprevalencestudy. J Clin Epidemiol 1991; 11: 1147–57.
3. Колосова О.А., Страчунская Е.Я. Электромиографическая характеристика различных вариантов головной боли напряжения. Материалы VII Всероссийского съезда неврологов. Нижний Новгород. 1995; 4: 94–8. 
4. Юдельсон Я.Б., Страчунская Е.Я. Головная боль. Смоленск, 1994.
5. D’Alessandro R, Gamberini G, Benassi G et al. Cluster headache in the Republic of San Marino. Cephalalgia 1986; 6: 159–62. 
6. Ekbom K, Svensson DA, Pedersen NL et al. Lifetime prevalence and concordance risk of cluster headache in the Swedish twin population. Neurology 2006; 67: 798–803. 
7. Evers S, Fischera M, May A et al. Prevalence of cluster headache in Germany: results of the epidemiological DMKG study. J Neurol Neurosurg Psychiatry 2007; 78: 1289–90.
8. Tonon C, Guttmann S, Volpini M et al. Prevalence and incidence of cluster headache in the Republic of San Marino. Neuro­logy 2002; 58: 1407–9. 
9. Torelli P, Beghi E, Manzoni GC. Cluster headache prevalence in the Italian general population. Neurology 2005; 64: 469–74.
10. Torelli P, Castellini P, Cucurachi L et al. Cluster headache prevalence: methodological considerations. Areviewoftheliterature. ActaBiomed 2006; 77: 4–9.
11. Torelli P, Manzoni GC. Pain and behaviour in cluster headache. A prospective study and review of the literature. Funct. Neurol 2003; 18: 205–10.
12. Kudrow L. The cyclic relationship of natural illumination to cluster period frequency. Cephalalgia 1987; 7: 76–8. 
13. Ekbom K. Evaluation of clinical criteria for cluster headache with special reference to the classification of the International Headache Society. Cephalalgia 1990; 10: 195–7.
14. Ekbom K. A clinical comparison of cluster headache and migraine. Acta Neurol Scand 1970;1.
15. Bahra A, May A, Goadsby PJ. Cluster headache: a prospective clinical study with diagnostic implications. Neurology 2002; 58: 354–61.
16. Donnet A, Lanteri-Minet M, Guegan-Massardier E et al. Chronic cluster headache: a French clinical descriptive study. J Neurol Neurosurg Psychiatry 2007; 78: 1354–8.
17. Olesen J, Bousser MG, Diener HC et al. Headache Classification Committee. New appendix criteria open for a broader concept of chronic migraine. Cephalalgia 2006; 26: 742–6.
18. Castillo J, Muñoz P, Guitera V, Pascual J. Kaplan Award 1998: Epidemiology of chronic daily headache in the general population. Headache 1999; 39: 190–6.
19. Scher AI, Midgette LA, Lipton RB. Risk factors for headache chronification. Headache 2008; 48: 16–25.
20. Karakurum B, Soylu O, Karataş M et al. Personality, depression, and anxiety as risk factors for chronic migraine. Int J Neurosci 2004; 114: 1391–9.
21. Dodick DW. Debate: Analgesic overuse is a cause not consequence, of chronic daily headache analgesic overuse is not a cause of chronic daily headache. Headache 2002; 42: 547–54.
22. Bigal ME, Lipton RB. What predicts the change from episodic to chronic migraine? CurrOpin Neurol 2009; 22: 269–76.
23. Pfaffenrath V, Isler H, Ekbom K. Chronic daily headache. Cephalalgia 1993; 13 (12): 66–7. 
24. Pfaffenrath V, Isler H. Evaluation of the nosology of chronic tension-type headache. Cephalalgia 1993; 13 (12): 60–2. 
25. Pfaffenrath V, Rath M, Pöllmann W, Keeser W. Atypical facial pain-application of the IHS criteria in a clinical sample. Cephalalgia 1993; 13 (12): 84–8.
26. Hoffman GS, Kerr GS, Leavitt RY et al. Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 1992; 116: 488–98. 
27. Reinhold-Keller E, Beuge N, Latza U et al. An interdisciplinary approach to the care of patients with Wegener’s granulomatosis, long-term outcome in 155 patients. Arthritis Rheum 2000; 43: 1021–32. 
28. Stone JH. Wegener's Granulomatosis Etanercept Trial Research Group. Limited versus severe Wegener's granulomatosis, baseline data on patients in the Wegener's granulomatosisetanercept trial. Arthritis Rheum 2003; 48: 2299–309.
29. Nishino H, Rubino FA, DeRemee RA et al. Neurological involvement in Wegener’s granulomatosis: an analysis of 324 consecutive patients at the Mayo Clinic. Ann Neurol 1993; 33: 4–9.
30. Seror R, Mahr A, Ramanoelina J et al. Central nervous system involvement in Wegener granulomatosis. Medicine (Baltimore) 2006; 85: 54–65.
31. Gonzalez-Gay MA, Barros S, Lopez-Diaz MJ et al. Giant cell arteritis: Disease patterns of clinical presentation in a series of 240 patients. Medicine (Baltimore) 2005; 84: 269–76.
32. Kernick D, Stapley S, Goadsby PJ, Hamilton W. What happens to new-onset headache presented to primary care? A case-cohort study using electronic primary care records. Cephalalgia 2008; 28: 1188–95.
33. Tanganelli P. Secondary headaches in the elderly. Neurol Sci 2010; 31 (1): S73–6.
34. Imai N, Kuroda R, Konishi T et al. Giant cell arteritis: clinical features of patients visiting a headache clinic in Japan. Intern Med 2011; 50 (16): 1679–82.
35. Maksimowicz-McKinnon K, Clark TM, Hoffman GS. Limitations of therapy and a guarded prognosis in an American cohort of Takayasu arteritis patients. Arthritis Rheum 2007; 56: 1000–9.
36. Li-xin Z, Jun N, Shan G. Neurological manifestations of Takayasu arteritis. Chin Med Sci J 2011; 26 (4): 227–30.
37. Wang Z, Shen L, Yu J et al. Management of cerebral ischemia due to Takayasu’s arteritis. Chin Med J (Engl) 2001; 115: 342–6.
38. Zhu WH, Shen LG, Neubauer H. Clinical characteristics, interdisciplinary treatment and follow-up of 14 children with Takayasu arteritis. World J Pediatr 2010; 6 (4): 342–7.
39. Cakar N, Yalcinkaya F, Duzova A et al. Takayasu arteritis in children. J Rheumatol 2008; 35 (5): 913–9.
40. Wattamwar PR, Doshi SA, Thomas B et al. Hypertrophic pachymeningitis in a patient with Takayasu arteritis: One more association? Ann Indian Acad Neurol 2012; 15 (1): 56–9.
41. Karande S, Jagtap S, Joshi A. Posterior reversible encephalopathy syndrome revealing Takayasu's arteritis. Indian J Pediatr 2009; 76 (2): 218–20.
42. Rosenberg MR, Parshley M, Gibson S, Wernick R. Central nervous system polyarteritisnodosa. West J Med 1990; 153: 553–6.
43. Pagnoux C, Seror R, Henegar C et al. French Vasculitis Study Group. Clinical features and outcomes in 348 patients with polyarteritisnodosa, a systematic retrospective study of patients diagnosed between 1963 and 2005 and entered into the French Vasculitis Study Group Database. Arthritis Rheum 2010; 62: 616–26.
44. Zenone T, Knefati Y, Sabatier JC. Polyarteritisnodosa presenting with jaw claudication and headache. Joint Bone Spine 2007; 74 (3): 301–2. 
45. Oh MS, Kim MH, Chu MK et al. Polyarteritisnodosa presenting with bilateral cavernous internal carotid artery aneurysms. Neurology 2008; 70 (5): 405. 
46. Kostina-O'Neil Y, Jirawuthiworavong GV, Podell DN, Les­ser RL. Choroidal and optic nerve infarction in hepatitis C-associated polyarteritisnodosa. J Neuroophthalmol 2007; 27 (3): 184–8. 
47. Song JS, Lim MK, Park BH, Park W. Acute pachymeningitis mimicking subdural hematoma in a patient withpolyarteritisnodosa. Rheumatol Int 2005; 25 (8): 637–40.
48. Al-Araji A, Kidd DP. Neuro-Behçet's disease, epidemiology; clinical characteristics; and management. Lancet Neurol 2009; 8 (2): 192–204. 
49. Ashjazadeh N, Borhani Haghighi A, Samangooie S, Moosavi H. Neuro-Behçet’s disease, a masquerader of multiple sclerosis. A prospective study of neurologic manifestations of Behçet’s disease in 96 Iranian patients. Exp Mol Pathol 2003; 74: 17–22.
50. Efthimiou P, Petryna O. Headache from cavernous sinus thrombosis in Adamantiades-Behçet disease. J Clin Rheumatol 2010; 16 (8): 409. 
51. el Bahri Ben Mrad F, Fredj M, Skandrani L et al. Cerebral venous thrombosis and Behçet's disease. Tunis Med 2002; 80 (2): 87–9. 
52. Alper G, Yilmaz Y, Ekinci G, Köse O. Cerebral vein thrombosis in Behçet's disease. Pediatr Neurol 2001; 25 (4): 332–5.
53. Akman-Demir G, Serdaroglu P, Tasçi B. Clinical patterns of neurological involvement in Behçet’s disease, evaluation of 200 patients. The Neuro-Behçet Study Group. Brain 1999; 122: 2171–82.
54. Origgi L, Vanoli M, Carbone A et al. Central nervous system involvement in patients with HCV-related cryoglobulinemia. Am J Med Sci 1998; 315: 208–10.
55. Kikuchi T, Yokoe I, Masuyama A et al. Behçet's disease initially presenting with meningitis and sudden hearing loss. Intern Med 2010; 49 (5): 483–6.
56. Serdaroglu P, Yazici H, Ozdemir C et al. Neurologic involvement in Behçet's syndrome. A prospective study. Arch Neurol 1989; 46: 265–9. 
57. Wechsler B, Dell’Isola B, Vidailhet M et al. MRU in 31 patients with Behçet's disease and neurological involvement: prospective study with clinical correlation. J Neurol Neurosurg Psychiatry 1993; 56: 793–8. 
58. Monastero R, Mannino M, Lopez G et al. Prevalence of headache in patients with Behçet's disease without overt neurological involvement. Cephalalgia 2003; 23: 105–8.
59. Volpinari S, Monaldini C, Capone JG et al. Headache in Behçet's disease: case-control study and literature review. Reumatismo 2009; 61 (3): 174–81.
60. Kidd D. The prevalence of headache in Behçet's syndrome. Rheumatology (Oxford) 2006; 45 (5): 621–3.
61. Borhani Haghighi A, Aflaki E, Ketabchi L. The prevalence and characteristics of different types of headache in patients with Behçet's disease, a case-control study. Headache 2008; 48 (3): 424–9.
62. Saip S, Siva A, Altintas A. Headache in Behçet's syndrome. Headache 2005; 45 (7): 911–9.
63. Unterman A, Nolte JE, Boaz M. Neuropsychiatric syndromes in systemic lupus erythematosus: a meta-analysis. Semin Arthritis Rheum 2011; 41 (1): 1–11.
64. Lessa B, Santana A, Lima I et al. Prevalence and classification of headache in patients with systemic lupus erythematosus. Clin Rheumatol 2006; 25 (6): 850–3.
65. Glanz BI, Venkatesan A, Schur PH et al. Prevalence of migraine in patients with systemic lupus erythematosus. Headache 2001; 41: 285–9.
66. Saver JL, Easton JD. Dissections and trauma of cervicocerebral arteries. In: Barnett HJM, Mohr JP, Stein BM, Yatsu FM (eds.) Stroke, edn. 3. New York: Churchill Livingstone 1998; 769–86. 
67. Jennekens FGI, Kater L. Neurology of the inflammatory connective tissue diseases. London: WB Saunders, 1999. 
68. De Bruyn SF, Stam J, Kapelle LJ. Thunderclap headache as first symptom of cerebral venous thrombosis. CVST Study Group. Lancet 1996; 348: 1623–5. 
69. Futran J, Shore A, Urowitz MB., Grossman H. Subdural hematoma in systemic lupus erythematosus: report and review of the literature. J Rheumatol 1987; 14: 378–81.
70. Isenberg DA, Meyrick-Thomas D, Snaith ML et al. A study of migraine in systemic lupus erythematosus. Ann Rheum Dis 1982; 41: 30–2.
71. Appenzeller O. Return to the headache in systemic lupus erythematosus using modern technology. Cephalalgia 1998; 18: 171–2.
72. Haji Muhammad Ismail Hussain I, Loh WF, Sofiah A. Childhood cerebral lupus in an Oriental population. Brain Dev 1999; 21: 229–35. 
73. Laversuch CJ, Brown MM, Clifton A, Bourke BE. Cerebral venous thrombosis and acquired protein S deficiency: an uncommon cause of headache in systemic lupus erythematosus. Br J Rheumatol 1995; 34: 572–5. 
74. Vidailhet M, Piette JC, Wechsler B et al. Cerebral venous thrombosis in systemic lupus erythematosus. Stroke 1990; 21: 1226–31. 
75. Yuen SY, Lau KF, Steinberg AW et al. Intracranial venous thrombosis and pulmonary embolism with antiphospholipid syndrome in systemic lupus erythematosus. J Paediatr Child Health 2001; 37: 405–8.
76. Bovim G, Jerstad S, Schrader H. Subdural hematoma presenting as headache in systemic lupus erythematosus. Cephalalgia 1990; 10 (1): 25–9.
77. Omdal R, Mellgren SI, Husby G. Clinical neuropsychiatric and neuromuscular manifestations in systemic lupus erythematosus. Scand J Rheumatol 1988; 17: 113–7.
78. Sfikakis PP, Mitsikostas DD, Manoussakis MN et al. Headache in systemic lupus erythematosus: a controlled study. Br J Rheumatol 1998; 37: 300–3.

Н.В.Пизова 

Кафедра нервных болезней и медицинской генетики с нейрохирургией ГБОУ ВПО ЯГМА Минздрава РФ